CHOVANEC, Josef, Zuzana DOSTÁLOVÁ, Julie BIENERTOVÁ VAŠKŮ, Anna VAŠKŮ and Atanas-Ivan BELKOV. Association of leptin and adiponectin polymorphisms with endometrial cancer. In International Journal of Gynecological Cancer. Supp 3. London, UK: Blackwell Publishing, 2006, p. 780-780.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Association of leptin and adiponectin polymorphisms with endometrial cancer
Name in Czech Asociace polymorfismů v genu pro leptin a adiponektin u pacientek s endometriálním karcinomem
Authors CHOVANEC, Josef (203 Czech Republic), Zuzana DOSTÁLOVÁ (203 Czech Republic), Julie BIENERTOVÁ VAŠKŮ (203 Czech Republic, guarantor), Anna VAŠKŮ (203 Czech Republic) and Atanas-Ivan BELKOV (203 Czech Republic).
Edition Supp 3. London, UK, International Journal of Gynecological Cancer, p. 780-780, 1 pp. 2006.
Publisher Blackwell Publishing
Other information
Original language English
Type of outcome Proceedings paper
Field of Study 30214 Obstetrics and gynaecology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/06:00017550
Organization unit Faculty of Medicine
Keywords in English Endometrial cancer; obesity; leptin; adiponectin; polymorphism
Tags adiponectin, endometrial cancer, leptin, obesity, polymorphism
Changed by Changed by: prof. MUDr. Julie Dobrovolná, Ph.D., učo 4805. Changed: 10/11/2006 14:56.
Abstract
Adiponectin is a recently described protein secreted by adipocytes, whose circulating levels are reduced in conditions related to insulin resistance and hyperinsulinemia. Leptin is small peptide produced by adipocytes and is implicated in a great number of endocrine regulations, whose impairment might result in obesity. The aim of this study was to investigate possible associations of previously described polymorphisms within the leptin (LEP -2548 G/A) and adiponectin gene (T94G) and development of endometrial cancer. Methods: Peripherial blood samples obtained of 16 women with endometrial cancer and 14 healthy controls were evaluated for leptin -2548 G/A and adiponectin T94G polymorphisms. Results: We did not found any significant differences in genotype distributions and allelic frequencies of both examined polymorphims (LEP -2548 G/A: pg=0.13 and Adipo T94G: pg=0.75) in endometrial cancer cases and controls. The endometrial cancer cases differed significantly from the controls in baseline patients characteristics, such as weight (p= < 0.0001), height (p= < 0.0001), LDL cholesterol plasma level (p=0.02) and spontaneous abortion rate (p=0.0006). Conclusions: Our results do not clearly support the hypothesis for leptin and adiponectin polymorphisms involvement in ethiopathogenesis of endometrial cancer. However, as this was a preliminary study, the number of cases in both cohorts might not be sufficient for finding a significant association.
Abstract (in Czech)
Naše studie nepodporuje hypotézu, že definovaná variabilita v genu pro leptin a adiponektin je faktorem velkému účinku v etiopatogenezi endometriálního karcinomu.
Links
MSM 141100002, plan (intention)Name: Molekulární patofyziologie multigenních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Molecular pathophysiology of multigene diseases
PrintDisplayed: 30/4/2024 22:47